Insider Transactions in Q1 2025 at Dyne Therapeutics, Inc. (DYN)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 05
2025
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
917
-0.74%
|
$10,087
$11.83 P/Share
|
|
Mar 05
2025
|
John Cox CEO & President |
SELL
Open market or private sale
|
Direct |
4,061
-2.7%
|
$44,671
$11.83 P/Share
|
|
Mar 05
2025
|
Douglas Kerr Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,343
-1.41%
|
$14,773
$11.83 P/Share
|
|
Mar 05
2025
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,094
-0.55%
|
$12,034
$11.83 P/Share
|
|
Feb 18
2025
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,598
-1.29%
|
$33,774
$13.95 P/Share
|
|
Feb 18
2025
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
2,488
-1.96%
|
$32,344
$13.95 P/Share
|
|
Jan 27
2025
|
Jason P Rhodes |
BUY
Grant, award, or other acquisition
|
Indirect |
1,111,111
+36.2%
|
$14,444,443
$13.5 P/Share
|